$130 Million is the total value of Wildcat Capital Management, LLC's 21 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
LPLA | LPL FINANCIAL HOLDINGS INC | $13,444,000 | -1.2% | 208,401 | 0.0% | 10.37% | -0.4% | |
SBR | SABINE ROYALTY TRUSTunit ben int | $12,236,000 | -9.9% | 289,963 | 0.0% | 9.44% | -9.1% | |
EDIT | EDITAS MEDICINE INC | $5,908,000 | -11.2% | 185,668 | 0.0% | 4.56% | -10.4% | |
SNNAQ | SIENNA BIOPHARMACEUTICALS IN | $4,381,000 | -2.4% | 295,613 | 0.0% | 3.38% | -1.6% | |
PLYA | PLAYA HOTELS & RESORTS NV | $2,889,000 | -10.8% | 300,000 | 0.0% | 2.23% | -10.1% | |
NK | NANTKWEST INC | $2,059,000 | +20.9% | 556,453 | 0.0% | 1.59% | +21.9% | |
SRNE | SORRENTO THERAPEUTICS INC | $1,829,000 | -38.9% | 415,765 | 0.0% | 1.41% | -38.4% | |
NH | NANTHEALTH INC | $315,000 | -52.5% | 200,373 | 0.0% | 0.24% | -52.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
COSTAR GROUP INC | 32 | Q3 2022 | 48.3% |
UROGEN PHARMA LTD | 26 | Q3 2023 | 17.3% |
META PLATFORMS INC | 26 | Q3 2023 | 9.9% |
ALLOGENE THERAPEUTICS INC | 18 | Q3 2023 | 22.4% |
GOOSEHEAD INSURANCE INC -A | 18 | Q3 2023 | 15.4% |
SABINE RTY TRUST | 18 | Q3 2021 | 11.3% |
LPL FINL HLDGS INC | 18 | Q1 2019 | 12.7% |
PLAYA HOTELS & RESORTS NV | 18 | Q3 2021 | 3.4% |
NANTKWEST INC | 17 | Q3 2019 | 22.0% |
SORRENTO THERAPEUTICS INC | 17 | Q2 2019 | 7.0% |
View Wildcat Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Skillz Inc. | January 05, 2023 | 19,596,988 | 5.6% |
UroGen Pharma Ltd. | February 14, 2022 | 533,139 | 2.4% |
Skillz Inc. | March 08, 2021 | 21,832,022 | 7.5% |
NantKwest, Inc. | February 13, 2018 | 808,974 | 1.0% |
Sorrento Therapeutics, Inc. | February 13, 2018 | 1,738,232 | 2.2% |
View Wildcat Capital Management, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
3 | 2024-04-08 |
SC 13G | 2024-04-08 |
13F-HR | 2024-02-13 |
13F-HR | 2023-11-09 |
PX14A6G | 2023-11-03 |
13F-HR | 2023-08-11 |
13F-HR/A | 2023-08-10 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-07 |
SC 13D/A | 2023-01-05 |
View Wildcat Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.